Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea
· Delayed Price · Currency is KRW 10,810
-60 (-0.55%)
Apr 29, 2026, 3:30 PM KST
Daewon Pharmaceutical Revenue
In the year 2025, Daewon Pharmaceutical had annual revenue of 605.43B KRW with 1.22% growth. Daewon Pharmaceutical had revenue of 159.81B in the quarter ending December 31, 2025.
Revenue
605.43B
Revenue Growth
+1.22%
P/S Ratio
0.38
Revenue / Employee
471.89M
Employees
1,283
Market Cap
232.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 605.43B | 7.27B | 1.22% |
| Dec 31, 2024 | 598.16B | 71.21B | 13.51% |
| Dec 31, 2023 | 526.95B | 48.07B | 10.04% |
| Dec 31, 2022 | 478.88B | 124.71B | 35.21% |
| Dec 31, 2021 | 354.18B | 45.68B | 14.81% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samjin Pharmaceuticals | 274.03B |
| Hyundai Pharmaceutical | 108.14B |
| Chong Kun Dang Holdings | 959.01B |
| Boditech Med | 162.09B |
| HLB Pharmaceutical | 205.58B |
| Suheung | 722.31B |
| AptaBio Therapeutics | 3.70B |
| Ilyang Pharmaceutical Co.,Ltd | 272.42B |